(Q39438955)

12 September 2017

Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin (English)

1 reference

12 September 2017

0 references

0 references

Schreck DM

1

1 reference

12 September 2017

Rivera AR

series ordinal

2

1 reference

12 September 2017

Tricarico VJ

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Annals of Emergency Medicine

12 September 2017

1 reference

12 September 2017

29

1 reference

12 September 2017

135-140

1 reference

12 September 2017

1

1 reference

Atrial fibrillation 1992. Management strategies in flux

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Management of atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

An "account" of digitalis and atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Efficacy and safety of intravenous diltiazem for treatment of atrial fibrillation and atrial flutter. The Diltiazem-Atrial Fibrillation/Flutter Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Pharmacokinetics and pharmacodynamics of intravenous diltiazem in patients with atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Efficacy and safety of medium- and high-dose diltiazem alone and in combination with digoxin for control of heart rate at rest and during exercise in patients with chronic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Effect of magnesium sulfate on ventricular rate control in atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Digoxin for converting recent-onset atrial fibrillation to sinus rhythm. A randomized, double-blinded trial

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Effects of intravenous diltiazem on rapid atrial fibrillation accompanied by congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Different cardiodepressant potency of various calcium antagonists in human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

Role of calcium antagonists for heart rate control in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2897%2970319-6

7 January 2021

10.1016/S0196-0644(97)70319-6

Identifiers

DOI

1 reference

12 September 2017

1 reference